Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
McKinsey
QuintilesIMS
Queensland Health
Accenture
Cipla

Generated: August 18, 2019

DrugPatentWatch Database Preview

Patent: 9,561,266

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,561,266
Title:Target peptides for immunotherapy and diagnostics
Abstract: A set of target peptides are presented by HLA A*0101, A*0201, A*0301, B*4402, B*2705, B*1402, and B*0702 on the surface of disease cells. They are envisioned to among other things (a) stimulate an immune response to the proliferative disease, e.g., cancer, (b) to function as immunotherapeutics in adoptive T cell therapy or as a vaccine, (c) facilitate antibody recognition of tumor boundaries in surgical pathology samples, (d) act as biomarkers for early detection and/or diagnosis of the disease, and (e) act as targets in the generation antibody-like molecules which recognize the target-peptide/MHC complex.
Inventor(s): Hunt; Donald F. (Charlottesville, VA), Shabanowitz; Jeffrey (Charlottesville, VA), Malaker; Stacy A. (Charlottesville, VA), Engelhard; Victor H. (Crozet, VA), Zarling; Angela (Richmond, VA), Cummings; Kara L. (Charlottesville, VA), Obeng; Rebecca C. (Charlottesville, VA), Cobbold; Mark (Birmingham, GB)
Assignee: University of Virginia Patent Foundation (Charlottesville, VA) The University of Birmingham (Birmingham, GB)
Application Number:14/424,702
Patent Claims:see list of patent claims

Details for Patent 9,561,266

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bristol Myers Squibb YERVOY ipilimumab INJECTABLE; INJECTION 125377 001 2011-03-25 ➤ Sign Up University of Virginia Patent Foundation (Charlottesville, VA) The University of Birmingham (Birmingham, GB) 2032-08-31 RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Boehringer Ingelheim
Fuji
Fish and Richardson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.